CSL Ltd
Save
130.23B
Market cap
34.11x
Current P/E
38.02x
Forward P/E
About
Health care
Sector
Biotechnology
Industry
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants.
Similar securities
Based on sector and market capitalization
Report issue